Mini Review

Published on 11 Jul 2024

Unveiling the role of O(6)-methylguanine-DNA methyltransferase in cancer therapy: insights into alkylators, pharmacogenomics, and others

in Cancer Molecular Targets and Therapeutics

Lizhen Chen
Alex Wen

Frontiers in Oncology

doi 10.3389/fonc.2024.1424797

Case Report

Accepted on 10 Jul 2024

Denosumab combined with chemotherapy followed by anlotinib in the treatment of multiple metastases of malignant peripheral nerve sheath tumor: A case report and literature review

in Cancer Molecular Targets and Therapeutics

Qian Chen
Kai Zheng
Ming Xu
chun xiu Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1399021

Original Research

Published on 09 Jul 2024

Enhancing breast cancer treatment: mesoporous dopamine nanoparticles in synergy with chrysin for photothermal therapy

in Cancer Molecular Targets and Therapeutics

Jing Zhu
Heng Zhang
Haomiao Lan
Bing Bi
Xianfeng Peng
Dandan Li
Haili Wang
Ke Zhu
Fuqiang Shao
Minggang Yin

Frontiers in Oncology

doi 10.3389/fonc.2024.1427858

108 views

Case Report

Published on 09 Jul 2024

Case report: Pyrotinib in the treatment of advanced scrotal EMPD combined with sweat gland carcinoma

in Cancer Molecular Targets and Therapeutics

Liquan Zhu
Haoqiang Wang
Donghai Cheng
Wei Wang
Yue Lei
Ning Yang
Lijun Peng
Peng Liu
Juan Zhou
Bo Xie

Frontiers in Oncology

doi 10.3389/fonc.2024.1382376

130 views

Original Research

Accepted on 08 Jul 2024

Trabectedin Emerges as the may be a Valuable Leading Choice Treatment Option for Elderly Patients with Metastatic Soft Tissue Sarcomas

in Cancer Molecular Targets and Therapeutics

Gianmaria Miolo
Angela Buonadonna
Davide Lombardi
Simona Scalone
Andrea Lauretta
Lara Della Puppa
Giuseppe Corona

Frontiers in Oncology

doi 10.3389/fonc.2024.1437732

Editorial

Published on 05 Jul 2024

Editorial: The MACC1 network in cancer

in Cancer Molecular Targets and Therapeutics

Wolfgang Walther
Franziska Siegel
Ulrike Stein

Frontiers in Oncology

doi 10.3389/fonc.2023.1343812

247 views

Perspective

Published on 04 Jul 2024

Immunotherapy and radiotherapy for older patients with invasive bladder cancer unfit for surgery or chemotherapy: practical proposal by the international geriatric radiotherapy group

in Cancer Molecular Targets and Therapeutics

Nam Phong Nguyen
Ulf Lennart Karlsson
Brandi R. Page
Monica-Emilia Chirila
Vincent Vinh-Hung
Olena Gorobets
Meritxell Arenas
Mohammad Mohammadianpanah
Seyed Alireza Javadinia
Huan Giap

Frontiers in Oncology

doi 10.3389/fonc.2024.1371752

328 views

Review

Accepted on 01 Jul 2024

Investigating Underlying Molecular Mechanisms, Signaling Pathways, Emerging Therapeutic Approaches in Pancreatic Cancer

in Cancer Molecular Targets and Therapeutics

Mohd Mustafa
Kashif Abbas
Mudassir Alam
SAFIA HABIB
.. Zulfareen
Gulam Mustafa Hasan
Sidra Islam
Anas Shamsi
Md Imtaiyaz Hassan

Frontiers in Oncology

doi 10.3389/fonc.2024.1427802

Original Research

Accepted on 01 Jul 2024

Type II mode of JAK2 inhibition and destabilization are potential therapeutic approaches against the ruxolitinib resistance driven myeloproliferative neoplasms

in Cancer Molecular Targets and Therapeutics

Sivahari Prasad Gorantla
Gerin Prince
Jasmin Osius
Dhurvas Chandrasekaran Dinesh
Vijay Kumar Boddu
Justus Duyster
Nikolas Von Bubnoff

Frontiers in Oncology

doi 10.3389/fonc.2024.1430833

Review

Accepted on 01 Jul 2024

Preclinical models for the study of pediatric solid tumors: Focus on bone sarcomas

in Cancer Molecular Targets and Therapeutics

D. Isabel Petrescu
Jason T Yustein
Atreyi Dasgupta

Frontiers in Oncology

doi 10.3389/fonc.2024.1388484

Original Research

Published on 01 Jul 2024

Comparison of 68Ga-FAP-2286 and 18F-FDG PET/CT in the diagnosis of advanced lung cancer

in Cancer Molecular Targets and Therapeutics

Feifan Xiang
Yue Zhang
Xiaoqi Tan
Jintao Zhang
Tengfei Li
Yuanzhuo Yan
Wenzhe Ma
Yue Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1413771

199 views

Original Research

Published on 01 Jul 2024

Pharmacological inhibition of CDK4/6 impairs diffuse pleural mesothelioma 3D spheroid growth and reduces viability of cisplatin-resistant cells

in Cancer Molecular Targets and Therapeutics

Aurora Costa
Iris Maria Forte
Francesca Pentimalli
Carmelina Antonella Iannuzzi
Luigi Alfano
Francesca Capone
Rosa Camerlingo
Alessandra Calabrese
Claudia von Arx
Reyes Benot Dominguez

Frontiers in Oncology

doi 10.3389/fonc.2024.1418951

160 views

Review

Accepted on 24 Jun 2024

Molecular characteristics and immune microenvironment of gastrointestinal stromal tumours: targets for therapeutic strategies

in Cancer Molecular Targets and Therapeutics

Yang Yu
Mengdie Yu
Lijie luo
zijing zhang
Haiping zeng
yan chen
Zeyu lin
mengnan chen
Wei Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1405727

Review

Published on 24 Jun 2024

Assessment of KRASG12C inhibitors for colorectal cancer

in Cancer Molecular Targets and Therapeutics

Gary A. Piazza
Preethi Chandrasekaran
Yulia Y. Maxuitenko
Karim I. Budhwani

Frontiers in Oncology

doi 10.3389/fonc.2024.1412435

535 views

Original Research

Accepted on 17 Jun 2024

The landscape of cancer-associated transcript fusions in adult brain tumors: a longitudinal assessment in 140 patients with cerebral gliomas and brain metastases

in Cancer Molecular Targets and Therapeutics

Philippe METELLUS
Clara CAMILLA
Emilie BIALECKI
Nathalie BEAUFILS
Christine VELLUTINI
Eric PELLEGRINO
Pascale TOMASINI
Manmeet Ahluwalia
Alireza Mansouri
Isabelle NANNI

Frontiers in Oncology

doi 10.3389/fonc.2024.1382394

Mini Review

Published on 17 Jun 2024

Non-immune functions of B7-H3: bridging tumor cells and the tumor vasculature

in Cancer Molecular Targets and Therapeutics

Shuo Wu
Chenxi Hu
Kaiyuan Hui
Xiaodong Jiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1408051

284 views

Navigation group

Articles

Unveiling the role of O(6)-methylguanine-DNA methyltransferase in cancer therapy: insights into alkylators, pharmacogenomics, and others

Denosumab combined with chemotherapy followed by anlotinib in the treatment of multiple metastases of malignant peripheral nerve sheath tumor: A case report and literature review

Enhancing breast cancer treatment: mesoporous dopamine nanoparticles in synergy with chrysin for photothermal therapy

Case report: Pyrotinib in the treatment of advanced scrotal EMPD combined with sweat gland carcinoma

Trabectedin Emerges as the may be a Valuable Leading Choice Treatment Option for Elderly Patients with Metastatic Soft Tissue Sarcomas

Editorial: The MACC1 network in cancer

Immunotherapy and radiotherapy for older patients with invasive bladder cancer unfit for surgery or chemotherapy: practical proposal by the international geriatric radiotherapy group

Investigating Underlying Molecular Mechanisms, Signaling Pathways, Emerging Therapeutic Approaches in Pancreatic Cancer

Type II mode of JAK2 inhibition and destabilization are potential therapeutic approaches against the ruxolitinib resistance driven myeloproliferative neoplasms

Preclinical models for the study of pediatric solid tumors: Focus on bone sarcomas

Comparison of 68Ga-FAP-2286 and 18F-FDG PET/CT in the diagnosis of advanced lung cancer

Pharmacological inhibition of CDK4/6 impairs diffuse pleural mesothelioma 3D spheroid growth and reduces viability of cisplatin-resistant cells

Molecular characteristics and immune microenvironment of gastrointestinal stromal tumours: targets for therapeutic strategies

Assessment of KRASG12C inhibitors for colorectal cancer

The landscape of cancer-associated transcript fusions in adult brain tumors: a longitudinal assessment in 140 patients with cerebral gliomas and brain metastases

Non-immune functions of B7-H3: bridging tumor cells and the tumor vasculature